Welcome to Fierce Biotech's fifth annual layoff tracker, a resource designed to keep pace with the sector's steady stream of workforce reductions. In 2025, industry layoffs continued to rise year over ...

Analytik Jena will be presenting new automation solutions for laboratory workflows at the SLAS 2026 International Conference ...

After five years, Nido Biosciences has reached the end of the road, closing its doors after its lead neurological disease candidate disappointed in a midstage study. Founded by 5AM Ventures’ 4:59 ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

A decade ago, entrepreneur PC Zhu was in the United States, starting up a Boston-based outfit helping biotech startups grow. Today he is in Shanghai, building one of the country’s most ambitious ...

Small and mid-cap biotech stocks entered 2025 like a compressed spring, and it finally snapped higher. “Biotech was a coiled spring following several quarters of underperformance,” Dr. Terry Smith, ...

Some of the best-selling drugs in the world are facing a loss of exclusivity in key jurisdictions in the upcoming years in what the sector calls "the patent cliff." The need for pharma to top up their ...

The performance metrics speak volumes. The iShares Biotechnology ETF (NASDAQ: IBB) has climbed 29.51% year to date through December 29, while the State Street SPDR S&P Biotech ETF (NASDAQ: XBI) has ...

Eli Lilly LLY0.53%increase; green up pointing triangle is in advanced talks to acquire Ventyx Biosciences VTYX 0.22%increase; green up pointing triangle for around $1 billion, according to people ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Thousands of workers lost their ...

Cathie Wood invested $1.33 million in biotech player after a challenging year for the stock. It focuses on in vivo gene editing, showing breakthroughs and facing safety setbacks in 2025. Financial ...

The President claimed in a rare primetime Oval Office address that the economy is doing well and will boom in 2026. Will it persuade the public? Plus Paul Gigot and Matthew Continetti on Trump's best ...